INC Research Establishes Site Advocacy Group to Improve Investigator Payments
INC Research announced the formation of a new Site Advocacy Group (SAG) under the auspices of its relationship with the Society for Clinical Research Sites (SCRS).
INC Research announced the formation of a new Site Advocacy Group (SAG) under the auspices of its relationship with the Society for Clinical Research Sites (SCRS). The Investigator Payment SAG, which will kick-off later this year, was established in response to specific feedback from sites that noted financial challenges to their ongoing sustainability as a participant in the clinical research enterprise. The Investigator Payment SAG aims to understand in depth the pain points sites experience and modernize financial processes to keep clinical research sites engaged, as well as recruit new sites.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
